Ligand Pharmaceuticals, Inc. (LGND)
183.98
-2.34
(-1.26%)
USD |
NASDAQ |
Feb 20, 16:00
183.59
-0.39
(-0.21%)
After-Hours: 20:00
Ligand Pharmaceuticals SG&A Expense (Quarterly) : 28.45M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| ADMA Biologics, Inc. | 23.05M |
| Johnson & Johnson | 6.753B |
| Elanco Animal Health, Inc. | 351.00M |
| Ionis Pharmaceuticals, Inc. | 96.81M |